- Home
- CGTX vs OVID Comparison
CGTX vs OVID Comparison
Compare CGTX & OVID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CGTX
- OVID
- Stock Information
- Founded
- CGTX 2007
- OVID 2014
- Country
- CGTX United States
- OVID United States
- Employees
- CGTX N/A
- OVID N/A
- Industry
- CGTX Biotechnology: Pharmaceutical Preparations
- OVID Biotechnology: Pharmaceutical Preparations
- Sector
- CGTX Health Care
- OVID Health Care
- Exchange
- CGTX Nasdaq
- OVID Nasdaq
- Market Cap
- CGTX 20.5M
- OVID 20.6M
- IPO Year
- CGTX 2021
- OVID 2017
- Fundamental
- Price
- CGTX $0.32
- OVID $0.29
- Analyst Decision
- CGTX Strong Buy
- OVID Strong Buy
- Analyst Count
- CGTX 5
- OVID 6
- Target Price
- CGTX $5.63
- OVID $2.78
- AVG Volume (30 Days)
- CGTX 1.7M
- OVID 457.6K
- Earning Date
- CGTX 05-07-2025
- OVID 05-13-2025
- Dividend Yield
- CGTX N/A
- OVID N/A
- EPS Growth
- CGTX N/A
- OVID N/A
- EPS
- CGTX N/A
- OVID N/A
- Revenue
- CGTX N/A
- OVID $548,000.00
- Revenue This Year
- CGTX N/A
- OVID N/A
- Revenue Next Year
- CGTX N/A
- OVID $21.49
- P/E Ratio
- CGTX N/A
- OVID N/A
- Revenue Growth
- CGTX N/A
- OVID 15.61
- 52 Week Low
- CGTX $0.22
- OVID $0.24
- 52 Week High
- CGTX $2.54
- OVID $3.31
- Technical
- Relative Strength Index (RSI)
- CGTX 47.90
- OVID 45.50
- Support Level
- CGTX $0.24
- OVID $0.27
- Resistance Level
- CGTX $0.34
- OVID $0.31
- Average True Range (ATR)
- CGTX 0.03
- OVID 0.02
- MACD
- CGTX -0.00
- OVID 0.00
- Stochastic Oscillator
- CGTX 68.84
- OVID 32.03
About CGTX Cognition Therapeutics Inc.
Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its product candidate CT1812, is an orally delivered, small-molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex.
About OVID Ovid Therapeutics Inc.
Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential best-in-class mechanism of action.